Pediatric Ontogeny: Ready for Incorporation into Modeling in Pediatric Drug Development?

Thursday, May 16, 2019
1:00 a.m.
NIH Main Campus, Natcher Conference Center, Bethesda, MD
cersi@umd.edu

National Institutes of Health - Main Campus
Natcher Conference Center
9000 Rockville Pike
Bethesda, MD 20892

Pediatric Ontogeny: Ready for Incorporation into Modeling in Pediatric Drug Development?

Modeling and simulation can reduce the numbers of pediatric patients to predict drug dose and effect, but such predictions rely on solid information on the ontogeny of the systems that interact with the new drug. The objectives of this workshop are to:

  • Review the present state of knowledge of the ontogeny of systems critical to drug dosing and effect in pediatric patients.
  • Discuss whether our knowledge of ontogeny of specific systems is adequate at the present time to make pediatric dosing and effect predictions through modeling and simulation.
  • Identify pathways forward for acquiring the additional information needed for incorporating ontogeny into modeling and simulation predictions for pediatric new drug development.

More information about this workshop will be made available online once a new date is chosen.

Note: This workshop was rescheduled from its original date in February due to the U.S. federal government shutdown.

If special accommodations at the workshop are needed due to a disability, please email Ann Anonsen ( aanonsen@umd.edu ) at least 7 days in advance of the workshop. Requests for sign language interpretation or Computer Aided Realtime Translation (CART)/captioning should be made 2 weeks in advance of the workshop and should be sent directly to the FDA Interpreting Services Staff email account: interpreting.services@oc.fda.gov.

Audience: Public 

 

April 2019

SU MO TU WE TH FR SA
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4
Submit an Event